BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22352893)

  • 1. CD33-related siglecs as potential modulators of inflammatory responses.
    Crocker PR; McMillan SJ; Richards HE
    Ann N Y Acad Sci; 2012 Apr; 1253():102-11. PubMed ID: 22352893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of leucocyte functions by CD33-related siglecs.
    Avril T; Attrill H; Zhang J; Raper A; Crocker PR
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease.
    McMillan SJ; Crocker PR
    Carbohydr Res; 2008 Aug; 343(12):2050-6. PubMed ID: 18279844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglecs as positive and negative regulators of the immune system.
    Crocker PR; Redelinghuys P
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1467-71. PubMed ID: 19021577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siglecs in innate immunity.
    Crocker PR
    Curr Opin Pharmacol; 2005 Aug; 5(4):431-7. PubMed ID: 15955740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglecs and their roles in the immune system.
    Crocker PR; Paulson JC; Varki A
    Nat Rev Immunol; 2007 Apr; 7(4):255-66. PubMed ID: 17380156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
    Miyazaki K; Sakuma K; Kawamura YI; Izawa M; Ohmori K; Mitsuki M; Yamaji T; Hashimoto Y; Suzuki A; Saito Y; Dohi T; Kannagi R
    J Immunol; 2012 May; 188(9):4690-700. PubMed ID: 22467657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting siglecs--a novel pharmacological strategy for immuno- and glycotherapy.
    Jandus C; Simon HU; von Gunten S
    Biochem Pharmacol; 2011 Aug; 82(4):323-32. PubMed ID: 21658374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
    Lock K; Zhang J; Lu J; Lee SH; Crocker PR
    Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
    Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
    J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.
    Fong JJ; Sreedhara K; Deng L; Varki NM; Angata T; Liu Q; Nizet V; Varki A
    EMBO J; 2015 Nov; 34(22):2775-88. PubMed ID: 26459514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
    Nguyen DH; Ball ED; Varki A
    Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
    Yousef GM; Ordon MH; Foussias G; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siglecs in the immune system.
    Crocker PR; Varki A
    Immunology; 2001 Jun; 103(2):137-45. PubMed ID: 11412300
    [No Abstract]   [Full Text] [Related]  

  • 17. Basic and clinical immunology of Siglecs.
    von Gunten S; Bochner BS
    Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2.
    Walter RB; Raden BW; Zeng R; Häusermann P; Bernstein ID; Cooper JA
    J Leukoc Biol; 2008 Jan; 83(1):200-11. PubMed ID: 17947393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siglecs, sialic acids and innate immunity.
    Crocker PR; Varki A
    Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.
    Angata T; Hayakawa T; Yamanaka M; Varki A; Nakamura M
    FASEB J; 2006 Oct; 20(12):1964-73. PubMed ID: 17012248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.